These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 780264)

  • 1. Inhibition of the alternative pathway of complement activation by a serum factor generated during transplant rejection.
    Spitzer R; Stitzel A; Florio L; Urmson J
    Immunochemistry; 1976 May; 13(5):395-400. PubMed ID: 780264
    [No Abstract]   [Full Text] [Related]  

  • 2. The functional significance of complement.
    Fearon DT; Ruddy S; Knostman JD; Carpenter CB; Austen KF
    Adv Nephrol Necker Hosp; 1974; 4():15-35. PubMed ID: 4219991
    [No Abstract]   [Full Text] [Related]  

  • 3. Chemistry and function of the complement system.
    Müller-Eberhard HJ
    Hosp Pract; 1977 Aug; 12(8):33-43. PubMed ID: 892784
    [No Abstract]   [Full Text] [Related]  

  • 4. The complement system and nephritis.
    Müller-Eberhard HJ
    Adv Nephrol Necker Hosp; 1974; 4():3-14. PubMed ID: 4143384
    [No Abstract]   [Full Text] [Related]  

  • 5. Cytotoxic action and other metabolic consequences of terminal complement proteins.
    Shin ML; Carney DF
    Prog Allergy; 1988; 40():44-81. PubMed ID: 3281171
    [No Abstract]   [Full Text] [Related]  

  • 6. Secretion of the terminal complement proteins, C5-C9, by human platelets.
    Houle JJ; Leddy JP; Rosenfeld SI
    Clin Immunol Immunopathol; 1989 Mar; 50(3):385-93. PubMed ID: 2917425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [C6, C7, C8 and C9].
    Hatanaka M; Kitano E
    Nihon Rinsho; 2010 Jun; 68 Suppl 6():90-3. PubMed ID: 20942009
    [No Abstract]   [Full Text] [Related]  

  • 8. Homologous species restriction in lysis of erythrocytes by terminal complement proteins.
    Hänsch GM; Hammer CH; Vanguri P; Shin ML
    Proc Natl Acad Sci U S A; 1981 Aug; 78(8):5118-21. PubMed ID: 6946459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The properdin pathway: mechanisms of complement activation and analogies to the classical pathway.
    Fearon DT; Austen KF; Ruddy S
    Rheumatology; 1975; 6():2-16. PubMed ID: 1105744
    [No Abstract]   [Full Text] [Related]  

  • 10. Terminal complement components play a role in the expression of C5a.
    Gresham HD; Renfer L; Hammer CH; Frank MM
    J Immunol; 1987 Feb; 138(3):838-41. PubMed ID: 3805718
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of immune haemolysis by a serum factor found in C3-deficient subjects.
    Kitamura H; Tsuboi M
    Immunology; 1989 Feb; 66(2):264-9. PubMed ID: 2925225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C56 formation in the reaction mixture of isolated complement components through the classical complement pathway.
    Kitamura H; Tsuboi M; Nagaki K
    Int Arch Allergy Appl Immunol; 1985; 78(1):101-7. PubMed ID: 4030125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Compliment system proteins: properties and biological activity (Lecture)].
    Kashkin KP; Dmitrieva LN
    Klin Lab Diagn; 2000 Jul; (7):25-32. PubMed ID: 10981394
    [No Abstract]   [Full Text] [Related]  

  • 14. Activation of therminal components of human complement by a trypsin-activated complex of human factor B and cobra venom factor.
    Miyama A; Kato T; Minoda I; Ueda T; Kashiba S
    Jpn J Microbiol; 1976 Dec; 20(6):507-16. PubMed ID: 1035353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Complement system].
    Korol' SA
    Fiziol Zh; 1977; 23(3):408-16. PubMed ID: 326583
    [No Abstract]   [Full Text] [Related]  

  • 16. Trypsin-activated complex of human factor B with cobra venom factor (CVF), cleaving C3 and C5 and generating a lytic factor for unsensitized guinea pig erythrocytes. I. Generation of the activated complex.
    Miyama A; Kato T; Horai S; Yokoo J; Kashiba S
    Biken J; 1975 Dec; 18(4):193-204. PubMed ID: 1218074
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of the fifth and sixth component of the complement system: similarities between C5b6 and C(56)a with respect to lytic enhancement by cell-bound C3b or A2C, and species preferences of target cell.
    Hänsch GM; Hammer CH; Mayer MM; Shin ML
    J Immunol; 1981 Sep; 127(3):999-1002. PubMed ID: 6911149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complement system in human colostrum: presence of nine complement components and factors of alternative pathway in human colostrum.
    Nakajima S; Baba AS; Tamura N
    Int Arch Allergy Appl Immunol; 1977; 54(5):428-33. PubMed ID: 885627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemolysis of normal human erythrocytes by autologous serum complement.
    Kitamura H; Nagano A; Kitano E
    Int Arch Allergy Immunol; 1993; 100(3):209-14. PubMed ID: 8453307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complement lysis of human erythrocytes. II. A unique interaction of human C8 and C9 with paroxysmal nocturnal hemoglobinuria erythrocytes.
    Packman CH; Rosenfeld SI; Jenkins DE; Leddy JP
    J Immunol; 1980 Jun; 124(6):2818-23. PubMed ID: 7189536
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.